

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of guanylate cyclase activity (GO:0031282) | 5.10846752 |
| 2 | NADH metabolic process (GO:0006734) | 5.00319632 |
| 3 | eosinophil chemotaxis (GO:0048245) | 4.90634262 |
| 4 | antibacterial humoral response (GO:0019731) | 4.81821350 |
| 5 | regulation of cellular extravasation (GO:0002691) | 4.76138679 |
| 6 | antimicrobial humoral response (GO:0019730) | 4.60017468 |
| 7 | eosinophil migration (GO:0072677) | 4.40610961 |
| 8 | positive regulation of respiratory burst (GO:0060267) | 4.36819579 |
| 9 | angiotensin maturation (GO:0002003) | 4.33089482 |
| 10 | positive regulation of pseudopodium assembly (GO:0031274) | 4.15049593 |
| 11 | positive regulation of guanylate cyclase activity (GO:0031284) | 4.09020078 |
| 12 | cytidine catabolic process (GO:0006216) | 3.73119010 |
| 13 | cytidine deamination (GO:0009972) | 3.73119010 |
| 14 | cytidine metabolic process (GO:0046087) | 3.73119010 |
| 15 | immunoglobulin mediated immune response (GO:0016064) | 3.72852402 |
| 16 | regulation of pseudopodium assembly (GO:0031272) | 3.71206458 |
| 17 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.66266927 |
| 18 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.58102154 |
| 19 | GDP-mannose metabolic process (GO:0019673) | 3.49430394 |
| 20 | regulation of triglyceride catabolic process (GO:0010896) | 3.48408494 |
| 21 | killing of cells of other organism (GO:0031640) | 3.47658210 |
| 22 | disruption of cells of other organism (GO:0044364) | 3.47658210 |
| 23 | ATP synthesis coupled proton transport (GO:0015986) | 3.35124590 |
| 24 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.35124590 |
| 25 | regulation of cGMP biosynthetic process (GO:0030826) | 3.27450393 |
| 26 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.23391145 |
| 27 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.21710466 |
| 28 | low-density lipoprotein particle remodeling (GO:0034374) | 3.19163621 |
| 29 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.16705469 |
| 30 | cellular response to zinc ion (GO:0071294) | 3.16294628 |
| 31 | epoxygenase P450 pathway (GO:0019373) | 3.12191223 |
| 32 | negative regulation of epidermal cell differentiation (GO:0045605) | 3.11435207 |
| 33 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 3.04978737 |
| 34 | T cell costimulation (GO:0031295) | 3.04204346 |
| 35 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.04054445 |
| 36 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.02965350 |
| 37 | regulation of antigen processing and presentation (GO:0002577) | 3.01409823 |
| 38 | lymphocyte costimulation (GO:0031294) | 3.00150092 |
| 39 | defense response to fungus (GO:0050832) | 2.99088797 |
| 40 | fructose metabolic process (GO:0006000) | 2.98651963 |
| 41 | cellular response to cadmium ion (GO:0071276) | 2.98030632 |
| 42 | positive regulation of antigen processing and presentation (GO:0002579) | 2.97904519 |
| 43 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 2.94389028 |
| 44 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.92893647 |
| 45 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.92083758 |
| 46 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 2.87630938 |
| 47 | B cell mediated immunity (GO:0019724) | 2.87044278 |
| 48 | tryptophan catabolic process (GO:0006569) | 2.84348005 |
| 49 | indole-containing compound catabolic process (GO:0042436) | 2.84348005 |
| 50 | indolalkylamine catabolic process (GO:0046218) | 2.84348005 |
| 51 | DNA deamination (GO:0045006) | 2.84317038 |
| 52 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.83723369 |
| 53 | protein neddylation (GO:0045116) | 2.81432007 |
| 54 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.81298345 |
| 55 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.80993723 |
| 56 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.79811741 |
| 57 | arginine metabolic process (GO:0006525) | 2.78359614 |
| 58 | regulation of respiratory burst (GO:0060263) | 2.77977859 |
| 59 | regulation of cGMP metabolic process (GO:0030823) | 2.77317966 |
| 60 | negative regulation of leukocyte migration (GO:0002686) | 2.77078222 |
| 61 | xenobiotic catabolic process (GO:0042178) | 2.75512157 |
| 62 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.73011239 |
| 63 | regulation of vitamin metabolic process (GO:0030656) | 2.72938952 |
| 64 | bile acid and bile salt transport (GO:0015721) | 2.72588641 |
| 65 | intestinal absorption (GO:0050892) | 2.71626267 |
| 66 | dendritic cell chemotaxis (GO:0002407) | 2.71226902 |
| 67 | actin nucleation (GO:0045010) | 2.70175543 |
| 68 | peptide catabolic process (GO:0043171) | 2.69027552 |
| 69 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.67513110 |
| 70 | digestion (GO:0007586) | 2.67252914 |
| 71 | glutathione biosynthetic process (GO:0006750) | 2.66040260 |
| 72 | sulfation (GO:0051923) | 2.65233644 |
| 73 | regulation of cellular respiration (GO:0043457) | 2.65035810 |
| 74 | neutrophil activation involved in immune response (GO:0002283) | 2.62560072 |
| 75 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.61719025 |
| 76 | respiratory electron transport chain (GO:0022904) | 2.60891438 |
| 77 | kynurenine metabolic process (GO:0070189) | 2.60763378 |
| 78 | electron transport chain (GO:0022900) | 2.60253228 |
| 79 | negative regulation of mast cell activation (GO:0033004) | 2.58449254 |
| 80 | glutathione derivative biosynthetic process (GO:1901687) | 2.57635408 |
| 81 | glutathione derivative metabolic process (GO:1901685) | 2.57635408 |
| 82 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 2.56094349 |
| 83 | amine catabolic process (GO:0009310) | 2.55551531 |
| 84 | cellular biogenic amine catabolic process (GO:0042402) | 2.55551531 |
| 85 | positive regulation of cGMP biosynthetic process (GO:0030828) | 2.55034295 |
| 86 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.52218526 |
| 87 | L-ascorbic acid metabolic process (GO:0019852) | 2.51612126 |
| 88 | negative regulation of heart rate (GO:0010459) | 2.51252945 |
| 89 | drug metabolic process (GO:0017144) | 2.49533345 |
| 90 | cyclooxygenase pathway (GO:0019371) | 2.48252501 |
| 91 | nucleoside diphosphate biosynthetic process (GO:0009133) | 2.47851150 |
| 92 | nonribosomal peptide biosynthetic process (GO:0019184) | 2.46885701 |
| 93 | vitamin A metabolic process (GO:0006776) | 2.45641962 |
| 94 | leukotriene biosynthetic process (GO:0019370) | 2.45156376 |
| 95 | leukotriene metabolic process (GO:0006691) | 2.44759742 |
| 96 | glutathione metabolic process (GO:0006749) | 2.44297169 |
| 97 | drug catabolic process (GO:0042737) | 2.44019845 |
| 98 | platelet dense granule organization (GO:0060155) | 2.42812301 |
| 99 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.42039813 |
| 100 | phosphatidylethanolamine acyl-chain remodeling (GO:0036152) | 2.40447691 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.77929127 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.26255309 |
| 3 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 4.03262201 |
| 4 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.76691617 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.83665375 |
| 6 | VDR_22108803_ChIP-Seq_LS180_Human | 2.21514372 |
| 7 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.07303724 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.06344791 |
| 9 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.03436922 |
| 10 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.03048068 |
| 11 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.00965540 |
| 12 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.00656188 |
| 13 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.00229184 |
| 14 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.99545664 |
| 15 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.89073875 |
| 16 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.84466046 |
| 17 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.80540977 |
| 18 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.79940833 |
| 19 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.77036147 |
| 20 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.70068977 |
| 21 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.65252815 |
| 22 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.65196675 |
| 23 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.64623072 |
| 24 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.61280586 |
| 25 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.60472614 |
| 26 | AR_20517297_ChIP-Seq_VCAP_Human | 1.57882340 |
| 27 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.56195364 |
| 28 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.54111915 |
| 29 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.51418022 |
| 30 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.49486756 |
| 31 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.49362383 |
| 32 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.49362383 |
| 33 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.46376937 |
| 34 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.46176514 |
| 35 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.43408306 |
| 36 | P300_27268052_Chip-Seq_Bcells_Human | 1.40973765 |
| 37 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.40703809 |
| 38 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.40096370 |
| 39 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.38118881 |
| 40 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.37628450 |
| 41 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.34901640 |
| 42 | SA1_27219007_Chip-Seq_Bcells_Human | 1.33169508 |
| 43 | GATA3_26560356_Chip-Seq_TH2_Human | 1.28922014 |
| 44 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 1.28085299 |
| 45 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.27412287 |
| 46 | SOX2_21211035_ChIP-Seq_LN229_Human | 1.24119416 |
| 47 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.24024980 |
| 48 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.23998784 |
| 49 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.23555591 |
| 50 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.21718712 |
| 51 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.21295679 |
| 52 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.20054680 |
| 53 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.19852041 |
| 54 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.19641457 |
| 55 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.19528058 |
| 56 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 1.19045220 |
| 57 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.18093934 |
| 58 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.15620444 |
| 59 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.15530772 |
| 60 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.14641233 |
| 61 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.13192425 |
| 62 | MYB_26560356_Chip-Seq_TH2_Human | 1.11923460 |
| 63 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.11107748 |
| 64 | P53_21459846_ChIP-Seq_SAOS-2_Human | 1.11105596 |
| 65 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.10372637 |
| 66 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.10227337 |
| 67 | ERA_21632823_ChIP-Seq_H3396_Human | 1.10096473 |
| 68 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.09773292 |
| 69 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.09417981 |
| 70 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.09091284 |
| 71 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.07536155 |
| 72 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.07175864 |
| 73 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.07083466 |
| 74 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.07043971 |
| 75 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06548426 |
| 76 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.05238314 |
| 77 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.04564725 |
| 78 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.03800047 |
| 79 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01906502 |
| 80 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.01048839 |
| 81 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.00266732 |
| 82 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.99518927 |
| 83 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.99261578 |
| 84 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.99098433 |
| 85 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.98705299 |
| 86 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.97643400 |
| 87 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.97239512 |
| 88 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.96958786 |
| 89 | NCOR_22424771_ChIP-Seq_293T_Human | 0.95976587 |
| 90 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.94764126 |
| 91 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.94314622 |
| 92 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.94115185 |
| 93 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.92519534 |
| 94 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.91686836 |
| 95 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.91270601 |
| 96 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.91059344 |
| 97 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.90640274 |
| 98 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.90640274 |
| 99 | SOX3_22085726_ChIP-Seq_MUSCLE_Mouse | 0.90340774 |
| 100 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.89172318 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 4.89372327 |
| 2 | MP0009379_abnormal_foot_pigmentation | 3.80332840 |
| 3 | MP0001835_abnormal_antigen_presentation | 3.50370792 |
| 4 | MP0010155_abnormal_intestine_physiology | 3.35070211 |
| 5 | MP0003806_abnormal_nucleotide_metabolis | 3.10929207 |
| 6 | MP0005671_abnormal_response_to | 3.09236473 |
| 7 | MP0002139_abnormal_hepatobiliary_system | 3.05503562 |
| 8 | MP0003724_increased_susceptibility_to | 2.79081812 |
| 9 | MP0001666_abnormal_nutrient_absorption | 2.76545395 |
| 10 | MP0004019_abnormal_vitamin_homeostasis | 2.65167747 |
| 11 | MP0005085_abnormal_gallbladder_physiolo | 2.50248830 |
| 12 | MP0009785_altered_susceptibility_to | 2.30985591 |
| 13 | MP0002148_abnormal_hypersensitivity_rea | 2.29184783 |
| 14 | MP0008875_abnormal_xenobiotic_pharmacok | 2.25221337 |
| 15 | MP0003436_decreased_susceptibility_to | 2.20922230 |
| 16 | MP0002876_abnormal_thyroid_physiology | 2.11877412 |
| 17 | MP0009764_decreased_sensitivity_to | 2.04742739 |
| 18 | MP0003866_abnormal_defecation | 2.02612219 |
| 19 | MP0009840_abnormal_foam_cell | 1.97747208 |
| 20 | MP0005464_abnormal_platelet_physiology | 1.91090910 |
| 21 | MP0005000_abnormal_immune_tolerance | 1.91071737 |
| 22 | MP0001800_abnormal_humoral_immune | 1.81353617 |
| 23 | MP0008872_abnormal_physiological_respon | 1.80893754 |
| 24 | MP0001845_abnormal_inflammatory_respons | 1.80377477 |
| 25 | MP0005365_abnormal_bile_salt | 1.78912871 |
| 26 | MP0006082_CNS_inflammation | 1.77981918 |
| 27 | MP0005387_immune_system_phenotype | 1.76861984 |
| 28 | MP0001790_abnormal_immune_system | 1.76861984 |
| 29 | MP0005025_abnormal_response_to | 1.70650647 |
| 30 | MP0004147_increased_porphyrin_level | 1.69458716 |
| 31 | MP0005645_abnormal_hypothalamus_physiol | 1.62565601 |
| 32 | MP0001873_stomach_inflammation | 1.57464618 |
| 33 | MP0002723_abnormal_immune_serum | 1.56608346 |
| 34 | MP0005166_decreased_susceptibility_to | 1.55604853 |
| 35 | MP0002452_abnormal_antigen_presenting | 1.54013162 |
| 36 | MP0000490_abnormal_crypts_of | 1.52621915 |
| 37 | MP0000685_abnormal_immune_system | 1.51540812 |
| 38 | MP0010329_abnormal_lipoprotein_level | 1.50691517 |
| 39 | MP0001819_abnormal_immune_cell | 1.47458587 |
| 40 | MP0003718_maternal_effect | 1.45836063 |
| 41 | MP0002420_abnormal_adaptive_immunity | 1.42914417 |
| 42 | MP0001664_abnormal_digestion | 1.42047303 |
| 43 | MP0009333_abnormal_splenocyte_physiolog | 1.37851964 |
| 44 | MP0001765_abnormal_ion_homeostasis | 1.37565868 |
| 45 | MP0002138_abnormal_hepatobiliary_system | 1.37514014 |
| 46 | MP0001533_abnormal_skeleton_physiology | 1.35620355 |
| 47 | MP0001663_abnormal_digestive_system | 1.35557835 |
| 48 | MP0003638_abnormal_response/metabolism_ | 1.33962770 |
| 49 | MP0003303_peritoneal_inflammation | 1.33828003 |
| 50 | MP0009643_abnormal_urine_homeostasis | 1.33563228 |
| 51 | MP0000465_gastrointestinal_hemorrhage | 1.33325999 |
| 52 | MP0003879_abnormal_hair_cell | 1.31560398 |
| 53 | MP0002166_altered_tumor_susceptibility | 1.30082331 |
| 54 | MP0002419_abnormal_innate_immunity | 1.28990662 |
| 55 | MP0005332_abnormal_amino_acid | 1.20364532 |
| 56 | MP0008469_abnormal_protein_level | 1.19863042 |
| 57 | MP0003252_abnormal_bile_duct | 1.15792861 |
| 58 | MP0003183_abnormal_peptide_metabolism | 1.14140484 |
| 59 | MP0005636_abnormal_mineral_homeostasis | 1.12939106 |
| 60 | MP0001919_abnormal_reproductive_system | 1.08946301 |
| 61 | MP0001756_abnormal_urination | 1.08035478 |
| 62 | MP0002136_abnormal_kidney_physiology | 1.03960284 |
| 63 | MP0000477_abnormal_intestine_morphology | 1.02766460 |
| 64 | MP0005167_abnormal_blood-brain_barrier | 0.98889223 |
| 65 | MP0000716_abnormal_immune_system | 0.97592276 |
| 66 | MP0002006_tumorigenesis | 0.96755351 |
| 67 | MP0006036_abnormal_mitochondrial_physio | 0.96120154 |
| 68 | MP0000538_abnormal_urinary_bladder | 0.95697411 |
| 69 | MP0003195_calcinosis | 0.95626630 |
| 70 | MP0005381_digestive/alimentary_phenotyp | 0.95532866 |
| 71 | MP0005451_abnormal_body_composition | 0.95528481 |
| 72 | MP0001905_abnormal_dopamine_level | 0.93501112 |
| 73 | MP0008004_abnormal_stomach_pH | 0.93310633 |
| 74 | MP0001501_abnormal_sleep_pattern | 0.92966727 |
| 75 | MP0005535_abnormal_body_temperature | 0.92779125 |
| 76 | MP0009763_increased_sensitivity_to | 0.91803013 |
| 77 | MP0001764_abnormal_homeostasis | 0.90341554 |
| 78 | MP0006072_abnormal_retinal_apoptosis | 0.90056504 |
| 79 | MP0001188_hyperpigmentation | 0.87978830 |
| 80 | MP0000230_abnormal_systemic_arterial | 0.87219760 |
| 81 | MP0004947_skin_inflammation | 0.86141859 |
| 82 | MP0003075_altered_response_to | 0.86078253 |
| 83 | MP0002118_abnormal_lipid_homeostasis | 0.85199162 |
| 84 | MP0005319_abnormal_enzyme/_coenzyme | 0.79242292 |
| 85 | MP0001485_abnormal_pinna_reflex | 0.78131613 |
| 86 | MP0008775_abnormal_heart_ventricle | 0.77733704 |
| 87 | MP0009642_abnormal_blood_homeostasis | 0.76268421 |
| 88 | MP0001970_abnormal_pain_threshold | 0.76114747 |
| 89 | MP0005367_renal/urinary_system_phenotyp | 0.75219780 |
| 90 | MP0000516_abnormal_urinary_system | 0.75219780 |
| 91 | MP0001986_abnormal_taste_sensitivity | 0.74073675 |
| 92 | MP0002429_abnormal_blood_cell | 0.74042584 |
| 93 | MP0005165_increased_susceptibility_to | 0.72303982 |
| 94 | MP0005058_abnormal_lysosome_morphology | 0.68779886 |
| 95 | MP0009765_abnormal_xenobiotic_induced | 0.68656497 |
| 96 | MP0002398_abnormal_bone_marrow | 0.67605537 |
| 97 | MP0000343_altered_response_to | 0.67529227 |
| 98 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.63289102 |
| 99 | MP0005410_abnormal_fertilization | 0.62002085 |
| 100 | MP0005174_abnormal_tail_pigmentation | 0.61865736 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 5.53866632 |
| 2 | Malnutrition (HP:0004395) | 4.05901163 |
| 3 | Systemic lupus erythematosus (HP:0002725) | 3.71551927 |
| 4 | Hydroxyprolinuria (HP:0003080) | 3.60203055 |
| 5 | Abnormality of proline metabolism (HP:0010907) | 3.60203055 |
| 6 | Nausea (HP:0002018) | 3.59268095 |
| 7 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.42220264 |
| 8 | Chronic diarrhea (HP:0002028) | 3.27264720 |
| 9 | Glycosuria (HP:0003076) | 3.16550301 |
| 10 | Abnormality of urine glucose concentration (HP:0011016) | 3.16550301 |
| 11 | Mitochondrial inheritance (HP:0001427) | 3.13119417 |
| 12 | Acute necrotizing encephalopathy (HP:0006965) | 3.08932116 |
| 13 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 3.08708412 |
| 14 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.02687544 |
| 15 | Hepatocellular necrosis (HP:0001404) | 3.02419784 |
| 16 | Abnormality of vitamin B metabolism (HP:0004340) | 2.90598987 |
| 17 | Hepatic necrosis (HP:0002605) | 2.85946960 |
| 18 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.84538387 |
| 19 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.84538387 |
| 20 | IgG deficiency (HP:0004315) | 2.84396818 |
| 21 | Petechiae (HP:0000967) | 2.78898735 |
| 22 | Congenital sensorineural hearing impairment (HP:0008527) | 2.76686222 |
| 23 | Congenital, generalized hypertrichosis (HP:0004540) | 2.75233293 |
| 24 | Acute encephalopathy (HP:0006846) | 2.66249575 |
| 25 | Increased CSF lactate (HP:0002490) | 2.65920482 |
| 26 | Hypoalbuminemia (HP:0003073) | 2.64715866 |
| 27 | Abnormal albumin level (HP:0012116) | 2.64715866 |
| 28 | Pustule (HP:0200039) | 2.62870908 |
| 29 | Xanthomatosis (HP:0000991) | 2.53890154 |
| 30 | Progressive macrocephaly (HP:0004481) | 2.52842132 |
| 31 | Increased muscle lipid content (HP:0009058) | 2.52462094 |
| 32 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.52352623 |
| 33 | Hypoproteinemia (HP:0003075) | 2.51177507 |
| 34 | Dicarboxylic aciduria (HP:0003215) | 2.50394568 |
| 35 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.50394568 |
| 36 | Increased intramyocellular lipid droplets (HP:0012240) | 2.50132236 |
| 37 | Posterior subcapsular cataract (HP:0007787) | 2.47250592 |
| 38 | Hyperphosphaturia (HP:0003109) | 2.43475416 |
| 39 | Abnormality of B cell number (HP:0010975) | 2.43250891 |
| 40 | Proximal tubulopathy (HP:0000114) | 2.41586403 |
| 41 | Widely patent fontanelles and sutures (HP:0004492) | 2.39069089 |
| 42 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.36739183 |
| 43 | Tongue fasciculations (HP:0001308) | 2.36656792 |
| 44 | Lethargy (HP:0001254) | 2.35916023 |
| 45 | Abnormality of alanine metabolism (HP:0010916) | 2.29887666 |
| 46 | Hyperalaninemia (HP:0003348) | 2.29887666 |
| 47 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.29887666 |
| 48 | Methylmalonic aciduria (HP:0012120) | 2.29205867 |
| 49 | Cerebral edema (HP:0002181) | 2.28167237 |
| 50 | Pancreatitis (HP:0001733) | 2.27077903 |
| 51 | Lipid accumulation in hepatocytes (HP:0006561) | 2.26454585 |
| 52 | Alkalosis (HP:0001948) | 2.23306531 |
| 53 | Vasculitis (HP:0002633) | 2.23040890 |
| 54 | Abnormality of serum amino acid levels (HP:0003112) | 2.20822235 |
| 55 | B lymphocytopenia (HP:0010976) | 2.19980557 |
| 56 | Microretrognathia (HP:0000308) | 2.19567804 |
| 57 | Abnormality of the prostate (HP:0008775) | 2.15993489 |
| 58 | Abnormality of magnesium homeostasis (HP:0004921) | 2.15464861 |
| 59 | Cerebral palsy (HP:0100021) | 2.14931035 |
| 60 | Decreased circulating renin level (HP:0003351) | 2.14813747 |
| 61 | Hyperlipoproteinemia (HP:0010980) | 2.14657792 |
| 62 | Alveolar cell carcinoma (HP:0006519) | 2.14018931 |
| 63 | Myositis (HP:0100614) | 2.13128591 |
| 64 | Hypobetalipoproteinemia (HP:0003563) | 2.12699108 |
| 65 | Abnormality of vitamin metabolism (HP:0100508) | 2.11737281 |
| 66 | Fat malabsorption (HP:0002630) | 2.10723335 |
| 67 | Lactic acidosis (HP:0003128) | 2.10506456 |
| 68 | Increased hepatocellular lipid droplets (HP:0006565) | 2.10079141 |
| 69 | Metabolic alkalosis (HP:0200114) | 2.08378562 |
| 70 | Exertional dyspnea (HP:0002875) | 2.06992580 |
| 71 | 3-Methylglutaconic aciduria (HP:0003535) | 2.06956964 |
| 72 | Abnormality of the costochondral junction (HP:0000919) | 2.03045180 |
| 73 | Purpura (HP:0000979) | 2.03015160 |
| 74 | Glomerulonephritis (HP:0000099) | 2.01140764 |
| 75 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.00905884 |
| 76 | Abnormal urine phosphate concentration (HP:0012599) | 1.99933967 |
| 77 | Obstructive lung disease (HP:0006536) | 1.98859801 |
| 78 | Chronic obstructive pulmonary disease (HP:0006510) | 1.98859801 |
| 79 | Generalized aminoaciduria (HP:0002909) | 1.98656103 |
| 80 | Pulmonary infiltrates (HP:0002113) | 1.97018766 |
| 81 | Muscle fibrillation (HP:0010546) | 1.94817203 |
| 82 | Decreased central vision (HP:0007663) | 1.94523051 |
| 83 | Conical tooth (HP:0000698) | 1.93004082 |
| 84 | Hypophosphatemia (HP:0002148) | 1.92954200 |
| 85 | Confusion (HP:0001289) | 1.92406974 |
| 86 | Hemoptysis (HP:0002105) | 1.91988904 |
| 87 | Encephalitis (HP:0002383) | 1.91006479 |
| 88 | Metabolic acidosis (HP:0001942) | 1.87252427 |
| 89 | Abnormality of macrophages (HP:0004311) | 1.86992495 |
| 90 | Stomatitis (HP:0010280) | 1.86149882 |
| 91 | Vomiting (HP:0002013) | 1.85240560 |
| 92 | Ileus (HP:0002595) | 1.83850988 |
| 93 | Acanthocytosis (HP:0001927) | 1.83126420 |
| 94 | Nephritis (HP:0000123) | 1.82369131 |
| 95 | Congenital stationary night blindness (HP:0007642) | 1.79858780 |
| 96 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.79651395 |
| 97 | Abnormality of complement system (HP:0005339) | 1.79051329 |
| 98 | Delayed epiphyseal ossification (HP:0002663) | 1.78624644 |
| 99 | Renal Fanconi syndrome (HP:0001994) | 1.77310913 |
| 100 | Steatorrhea (HP:0002570) | 1.77186629 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K12 | 3.52351015 |
| 2 | GRK6 | 3.13404524 |
| 3 | MYLK | 2.94784566 |
| 4 | CDK19 | 2.91002105 |
| 5 | NUAK1 | 2.77673412 |
| 6 | BMPR2 | 2.61144145 |
| 7 | ACVR1B | 2.58143227 |
| 8 | TLK1 | 2.43040691 |
| 9 | TAOK3 | 2.24530054 |
| 10 | TESK2 | 2.16327785 |
| 11 | MAP4K1 | 2.03075482 |
| 12 | BCKDK | 1.95443597 |
| 13 | ILK | 1.92999372 |
| 14 | GRK1 | 1.91306057 |
| 15 | MST4 | 1.89427730 |
| 16 | TXK | 1.89427051 |
| 17 | IKBKB | 1.74393984 |
| 18 | MAP4K2 | 1.72767411 |
| 19 | KDR | 1.67591822 |
| 20 | TBK1 | 1.65856128 |
| 21 | ADRBK2 | 1.59683906 |
| 22 | MAP3K11 | 1.48857660 |
| 23 | IKBKE | 1.41057106 |
| 24 | ERN1 | 1.37541591 |
| 25 | CSF1R | 1.34906059 |
| 26 | RIPK4 | 1.31317952 |
| 27 | EPHB2 | 1.28498545 |
| 28 | OXSR1 | 1.26967121 |
| 29 | PRKG2 | 1.26002585 |
| 30 | SYK | 1.25915964 |
| 31 | LYN | 1.20547667 |
| 32 | MAP2K2 | 1.19649863 |
| 33 | TESK1 | 1.18705809 |
| 34 | TEC | 1.10373937 |
| 35 | KIT | 1.09165294 |
| 36 | ERBB3 | 1.09137356 |
| 37 | TIE1 | 1.08384994 |
| 38 | DAPK3 | 1.07940263 |
| 39 | LCK | 1.00845271 |
| 40 | BTK | 0.99420421 |
| 41 | ITK | 0.97663148 |
| 42 | WNK4 | 0.96918034 |
| 43 | PIM2 | 0.96645757 |
| 44 | FRK | 0.94971821 |
| 45 | DAPK2 | 0.94008344 |
| 46 | PDK2 | 0.93574049 |
| 47 | FES | 0.92627096 |
| 48 | ABL2 | 0.91912140 |
| 49 | MUSK | 0.84296505 |
| 50 | DAPK1 | 0.83755000 |
| 51 | DYRK2 | 0.82910794 |
| 52 | EPHA2 | 0.79914202 |
| 53 | JAK3 | 0.79852799 |
| 54 | GRK5 | 0.79673609 |
| 55 | ZAK | 0.79247154 |
| 56 | STK16 | 0.77728983 |
| 57 | TRPM7 | 0.75870111 |
| 58 | MATK | 0.75725562 |
| 59 | CSK | 0.75347709 |
| 60 | LIMK1 | 0.74053995 |
| 61 | PIM1 | 0.72792925 |
| 62 | PRKCA | 0.71683944 |
| 63 | PRKCQ | 0.70939823 |
| 64 | FLT3 | 0.70117647 |
| 65 | MAPKAPK5 | 0.69092874 |
| 66 | WNK3 | 0.68956222 |
| 67 | PIK3CG | 0.67091693 |
| 68 | MST1R | 0.64623997 |
| 69 | ZAP70 | 0.63161894 |
| 70 | BLK | 0.62768454 |
| 71 | PRKACG | 0.62368957 |
| 72 | BMX | 0.61022844 |
| 73 | INSRR | 0.60324881 |
| 74 | PTK2B | 0.58751909 |
| 75 | PTK6 | 0.58565183 |
| 76 | ERBB2 | 0.57233793 |
| 77 | RPS6KA5 | 0.55277267 |
| 78 | JAK1 | 0.54981053 |
| 79 | PRKCE | 0.54344518 |
| 80 | MAP3K14 | 0.52916174 |
| 81 | IGF1R | 0.52017722 |
| 82 | SIK3 | 0.49925699 |
| 83 | MAPKAPK3 | 0.49042406 |
| 84 | PRKACA | 0.48702638 |
| 85 | PAK1 | 0.48565207 |
| 86 | CSNK1G3 | 0.48525062 |
| 87 | GRK7 | 0.48274231 |
| 88 | PRKCD | 0.48218290 |
| 89 | TYK2 | 0.47989191 |
| 90 | EIF2AK3 | 0.47763290 |
| 91 | MAP2K7 | 0.47174958 |
| 92 | MARK3 | 0.46522492 |
| 93 | CAMKK2 | 0.44451474 |
| 94 | PRKG1 | 0.44122645 |
| 95 | MAPK13 | 0.43985508 |
| 96 | ABL1 | 0.43504550 |
| 97 | MINK1 | 0.43066203 |
| 98 | ADRBK1 | 0.41447432 |
| 99 | TRIM28 | 0.41165711 |
| 100 | PRKCZ | 0.38082661 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Asthma_Homo sapiens_hsa05310 | 4.77140375 |
| 2 | Allograft rejection_Homo sapiens_hsa05330 | 3.57770782 |
| 3 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.57108399 |
| 4 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.44629059 |
| 5 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.38587849 |
| 6 | Caffeine metabolism_Homo sapiens_hsa00232 | 3.02802076 |
| 7 | Fat digestion and absorption_Homo sapiens_hsa04975 | 3.00464631 |
| 8 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.85353471 |
| 9 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.67920712 |
| 10 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 2.35287119 |
| 11 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.28202008 |
| 12 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.10196885 |
| 13 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.88165571 |
| 14 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.85314214 |
| 15 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.83279540 |
| 16 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.82642068 |
| 17 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.75653754 |
| 18 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.75383936 |
| 19 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.72865970 |
| 20 | Viral myocarditis_Homo sapiens_hsa05416 | 1.62602670 |
| 21 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.55257438 |
| 22 | Mineral absorption_Homo sapiens_hsa04978 | 1.50738742 |
| 23 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.48858396 |
| 24 | Parkinsons disease_Homo sapiens_hsa05012 | 1.44046066 |
| 25 | Leishmaniasis_Homo sapiens_hsa05140 | 1.39030448 |
| 26 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.35725362 |
| 27 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.32396441 |
| 28 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.29136091 |
| 29 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.23103215 |
| 30 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.21678264 |
| 31 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.21042389 |
| 32 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.20291345 |
| 33 | Proteasome_Homo sapiens_hsa03050 | 1.04915311 |
| 34 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.03431311 |
| 35 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.02847179 |
| 36 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.02706170 |
| 37 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.01395781 |
| 38 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.99949873 |
| 39 | Histidine metabolism_Homo sapiens_hsa00340 | 0.96446406 |
| 40 | Alzheimers disease_Homo sapiens_hsa05010 | 0.93987066 |
| 41 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.91365915 |
| 42 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.88452635 |
| 43 | Retinol metabolism_Homo sapiens_hsa00830 | 0.88334492 |
| 44 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.88006183 |
| 45 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.87319778 |
| 46 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.85138232 |
| 47 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.78454693 |
| 48 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.77696060 |
| 49 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.75467023 |
| 50 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.74630350 |
| 51 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.73637797 |
| 52 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.72164176 |
| 53 | Huntingtons disease_Homo sapiens_hsa05016 | 0.71287721 |
| 54 | Tuberculosis_Homo sapiens_hsa05152 | 0.69739472 |
| 55 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.68081775 |
| 56 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.66668895 |
| 57 | Ribosome_Homo sapiens_hsa03010 | 0.65690821 |
| 58 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.65574393 |
| 59 | Phagosome_Homo sapiens_hsa04145 | 0.65024194 |
| 60 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.61057093 |
| 61 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.60479919 |
| 62 | Peroxisome_Homo sapiens_hsa04146 | 0.59315149 |
| 63 | Pertussis_Homo sapiens_hsa05133 | 0.58941435 |
| 64 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.57217684 |
| 65 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.56860634 |
| 66 | Phototransduction_Homo sapiens_hsa04744 | 0.56494343 |
| 67 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.55214893 |
| 68 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.55084064 |
| 69 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.55002631 |
| 70 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.53635920 |
| 71 | Protein export_Homo sapiens_hsa03060 | 0.50516849 |
| 72 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.48295506 |
| 73 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.46700506 |
| 74 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.46202451 |
| 75 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.44973574 |
| 76 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.43558374 |
| 77 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.43495086 |
| 78 | Bile secretion_Homo sapiens_hsa04976 | 0.41071503 |
| 79 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.40337405 |
| 80 | Influenza A_Homo sapiens_hsa05164 | 0.39460980 |
| 81 | Metabolic pathways_Homo sapiens_hsa01100 | 0.33675534 |
| 82 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.33154603 |
| 83 | Sulfur relay system_Homo sapiens_hsa04122 | 0.32088297 |
| 84 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.31603942 |
| 85 | Galactose metabolism_Homo sapiens_hsa00052 | 0.30117509 |
| 86 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.30034619 |
| 87 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.29988489 |
| 88 | Salmonella infection_Homo sapiens_hsa05132 | 0.29897609 |
| 89 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.26455128 |
| 90 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.25071540 |
| 91 | Lysosome_Homo sapiens_hsa04142 | 0.25040885 |
| 92 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.23857854 |
| 93 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.22973913 |
| 94 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.21673474 |
| 95 | Salivary secretion_Homo sapiens_hsa04970 | 0.21592818 |
| 96 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.21386636 |
| 97 | RNA polymerase_Homo sapiens_hsa03020 | 0.20443085 |
| 98 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.18020771 |
| 99 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.16876162 |
| 100 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.16801383 |

